Diagnostic Accuracy of Ga-68-HBED-CC-PSMA-Ligand-PET/CT before Salvage Lymph Node Dissection for Recurrent Prostate Cancer

被引:113
|
作者
Jilg, Cordula A. [1 ]
Drendel, Vanessa [2 ]
Rischke, H. Christian [3 ,4 ]
Beck, Teresa [4 ]
Vach, Werner [5 ,6 ]
Schaal, Kathrin [1 ]
Wetterauer, Ulrich [1 ]
Schultze-Seemann, Wolfgang [1 ]
Meyer, Philipp T. [4 ,7 ]
机构
[1] Univ Freiburg, Fac Med, Med Ctr, Dept Urol, Freiburg, Germany
[2] Univ Freiburg, Fac Med, Inst Pathol, Freiburg, Germany
[3] Univ Freiburg, Fac Med, Med Ctr, Dept Radiat Oncol, Freiburg, Germany
[4] Univ Freiburg, Fac Med, Med Ctr, Dept Nucl Med, Freiburg, Germany
[5] Univ Freiburg, Fac Med, Inst Med Biometry & Stat, Freiburg, Germany
[6] Univ Freiburg, Med Ctr, Freiburg, Germany
[7] DKTK, German Canc Consortium, Partner Site Freiburg, Freiburg, Germany
来源
THERANOSTICS | 2017年 / 7卷 / 06期
关键词
prostate cancer; lymph node metastases; PSMA-PET/CT; salvage lymph node dissection; salvage lymphadenectomy; EAU GUIDELINES; PET/CT; LIGAND;
D O I
10.7150/thno.18421
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Background: By targeting the prostate-specific membrane antigen (PSMA) on prostate cancer (PCa) cells PSMA-PET/CT shows great potential in locating the site of biochemical recurrence even at low PSA (Prostate-specific antigen)-levels. Accurate imaging of PCa recurrent lymph node metastases (LNM) is crucial for metastases directed therapies such as salvage-lymph node dissection (salvage-LND). Objective: To evaluate the diagnostic accuracy of PSMA-PET/CT for detection of affected lymph-node regions at salvage-LND for nodal recurrence of PCa. Design, setting and participants: 30 patients with the suspicion of exclusively nodal PCa-relapse after primary therapy underwent a template pelvic and/or retroperitoneal salvage-LND after whole body 68-Ga-PSMA-PET/CT. The diagnostic accuracy of PET/CT was evaluated in comparison to the histopathology of 965 resected lymph nodes (LN) dissected from 68 main regions (pelvic left/right, retroperitoneal) and 289 subregions (common iliac, external iliac, obturator, internal iliac, presacral, aortic-bifurcation, aortal, caval). LNM and tumor deposits in LNM were measured bidimensionally in the histopathology. PSMA-expression was analyzed by immunohistochemistry in LNM. Results: LNM were present in 11.4% of the resected LN (110/965) resulting in 45 positive main regions and 85 positive subregions. PET/CT was true positive in 41 main regions and 69 subregions. Three PET-negative main regions and 16 PET-negative subregions finally contained LNM, the majority of these false negative subregions (13/16) were in neighboring regions of true-positive subregions. Sensitivity, specificity, positive predictive value, negative predictive value and accuracy were: main region-based 93.2%, 100%, 100%, 88.9% and 95.6%, subregion-based 81.2%, 99.5%, 98.6%, 92.7 and 94.1%. Median short diameters of tumor deposits in LNM resected from false-negative subregions (1.3 mm) were significantly smaller than in LNM removed from true-positive subregions (5.5 mm, p<0.0001). Based on anatomical subregions containing just one LNM, the necessary short diameter of tumor deposits in LNM required to reach a detection rate of 50% and 90% was estimated to be >= 2.3 mm and >= 4.5 mm, respectively. Conclusion: In men with biochemical PCa-relapse and positive PSMA-PET/CT, PET/CT detects metastatic affected anatomical regions with high accuracy at a main region and at a subregion-level. If the decision for salvage-LND is prompted by a positive PSMA-PET/CT, the size of metastases is crucial for accurate detection of affected regions. All LNM showed a clear PSMA-expression in the immunohistochemistry. Further studies need to investigate how to translate the high anatomical correlation observed between PET/CT and surgical findings into optimal approaches for target salvage-LND.
引用
收藏
页码:1770 / 1780
页数:11
相关论文
共 50 条
  • [31] THE DIAGNOSTIC VALUE OF 68GA-LABELLED PSMA-LIGAND PET/CT IN MEN WITH RECURRENT PROSTATE CANCER
    Hadaschik, Boris
    Afshar-Oromieh, Ali
    Radtke, Jan
    Boxler, Silvan
    Eder, Matthias
    Kopka, Klaus
    Debus, Juergen
    Hohenfellner, Markus
    Haberkorn, Uwe
    JOURNAL OF UROLOGY, 2015, 193 (04): : E638 - E638
  • [32] PET/CT evaluation of prostate cancer patients with Al18F-PSMA-HBED-CC: a head-to-head comparison with 68Ga-PSMA-HBED-CC.
    Alonso, Omar
    dos Santos, Gerardo
    Giglio, Javier
    Savio, Eduardo
    Engler, Henry
    JOURNAL OF NUCLEAR MEDICINE, 2018, 59
  • [34] Performance of [68Ga] Ga-PSMA 11 PET for detecting prostate cancer in the lymph nodes before salvage lymph node dissection: a systematic review and meta-analysis
    Shoji Kimura
    Mohammad Abufaraj
    Florian Janisch
    Takehiro Iwata
    Mehdi Kardoust Parizi
    Beat Foerster
    Nicola Fossati
    Alberto Briganti
    Shin Egawa
    Markus Hartenbach
    Shahrokh F. Shariat
    Prostate Cancer and Prostatic Diseases, 2020, 23 : 1 - 10
  • [35] Salvage lymph node dissection after 68Ga-PSMA or 18F-FEC PET/CT for nodal recurrence in prostate cancer patients
    Herlemann, Annika
    Kretschmer, Alexander
    Buchner, Alexander
    Karl, Alexander
    Tritschler, Stefan
    El-Malazi, Lina
    Fendler, Wolfgang P.
    Wenter, Vera
    Ilhan, Harun
    Bartenstein, Peter
    Stief, Christian G.
    Gratzke, Christian
    ONCOTARGET, 2017, 8 (48) : 84180 - 84192
  • [36] Performance of [68Ga] Ga-PSMA 11 PET for detecting prostate cancer in the lymph nodes before salvage lymph node dissection: a systematic review and meta-analysis
    Kimura, Shoji
    Abufaraj, Mohammad
    Janisch, Florian
    Iwata, Takehiro
    Parizi, Mehdi Kardoust
    Foerster, Beat
    Fossati, Nicola
    Briganti, Alberto
    Egawa, Shin
    Hartenbach, Markus
    Shariat, Shahrokh F.
    PROSTATE CANCER AND PROSTATIC DISEASES, 2020, 23 (01) : 1 - 10
  • [37] Evaluation of PSMA PET/CT imaging using a 68Ga-HBED-CC ligand in patients with prostate cancer and the value of early pelvic imaging
    Kabasakal, Levent
    Demirci, Emre
    Ocak, Meltem
    Akyel, Resit
    Nematyazar, Jamal
    Aygun, Aslan
    Halac, Metin
    Talat, Zubeyir
    Araman, Ahmet
    NUCLEAR MEDICINE COMMUNICATIONS, 2015, 36 (06) : 582 - 587
  • [38] 68Ga-HBED-CC-PSMA PET/CT versus histopathology in primary localized prostate cancer: a voxelwise comparison
    Zamboglou, C.
    Schiller, F.
    Fechter, T.
    Wieser, G.
    Drendel, V
    Jilg, C. A.
    Chirindel, A.
    Salman, N.
    Mix, M.
    Meyer, P. T.
    Grosu, A. L.
    STRAHLENTHERAPIE UND ONKOLOGIE, 2016, 192 : 50 - 50
  • [39] Role of early dynamic PET/CT with 68Ga-PSMA-HBED-CC in patients with adenocarcinoma prostate
    Perveen, Gazala
    Arora, Geetanjali
    Damle, Nishikant
    Gupta, Ravikant
    Tripathi, Madhavi
    Bal, Chandrasekhar
    Kumar, Praveen
    Rajeev, Kumar
    Prabhu, Meghana
    Singh, Prabhjot
    Das, Chandan
    JOURNAL OF NUCLEAR MEDICINE, 2018, 59
  • [40] 68Ga-HBED PSMA PET/CT IN THE ASSESSMENT OF BIOCHEMICAL RECURRENCE IN PROSTATE CANCER
    Nadebaum, D.
    Grummet, J.
    Beech, P.
    Barber, T.
    Yap, K.
    Cherk, M.
    INTERNAL MEDICINE JOURNAL, 2017, 47 : 21 - 21